कृपया अन्य खोज का प्रयास करें
Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Jason D. Hanson | 54 | 2023 | Independent Director |
Sanjay Vashee | - | - | Scientific Advisor |
Gregory Riggins | - | - | Scientific Advisor |
R. Donald Elsey | 69 | 2023 | Independent Director |
Vininder Singh | 53 | 2017 | Founder, Chairman & CEO |
William J. Enright | 60 | 2023 | Independent Director |
Jeremiah Wala | - | 2023 | Scientific Advisor |
Gwenn Smith | - | 2023 | Scientific Advisor |
Cetin Savkli | - | 2023 | Chief AI Advisor & Member of Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है